Pfizer generated free cash flow of $10.4 billion in the 12 months ending Sept. 30, 2025. During this period, the pharma giant ...
Money Talks News on MSN
10 drugs that just got cheaper for millions of people on Medicare
Beginning this year, Medicare's new negotiated drug prices could cut prescription costs in half for millions of seniors, a ...
WhiteSands Alcohol & Drug Rehab Lakeland has published a new in-depth educational resource on its website examining the medical and behavioral risks associated with mixing Eliquis, a commonly ...
In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the maximum price drug manufacturers can charge Medicare plans for 10 popular ...
In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the ...
Savings for Part D and Advantage enrollees depend largely on which plan they’re enrolled in, as not all plans are the same.
Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday. How much those savings will be ...
Bristol-Myers Squibb Company (NYSE:BMY) presents a measured balance between risk and reward. The stock offers a 4.6% dividend ...
Could the pharmaceutical giant turn things around next year? Let's find out whether Bristol Myers Squibb is a buy, sell, or ...
Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops, and delivers advanced ...
Looking toward 2026, several changes are set to ease the financial burden, including a 2.8% cost-of-living increase for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results